ea0065p283 | Neuroendocrinology | SFEBES2019
Nuttall Ciara
, Izzi-Engbeaya Chioma
, Mendoza Nigel
, Nair Ramesh
, Abbara Ali
, Martin Niamh
, Hatfield Emma
Background: Acromegaly is associated with multiple co-morbidities and increased mortality. Surgery is the first-line intervention and remission of acromegaly can restore normal life-expectancy. Pre-operative somatostatin analogues (SSA) may increase the likelihood of remission in large invasive tumours by causing tumour shrinkage prior to surgery.Aims: To audit the management of acromegaly patients at Imperial College Healthcare NHS Trust (ICHNT) against...